ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $482,548 | +24.9% | 134,790 | +28.7% | 0.00% | – |
| Q2 2023 | $386,350 | +13.9% | 104,702 | +2.2% | 0.00% | – |
| Q1 2023 | $339,199 | -19.9% | 102,477 | -6.1% | 0.00% | – |
| Q4 2022 | $423,503 | +118.3% | 109,150 | +36.8% | 0.00% | – |
| Q3 2022 | $194,000 | -27.1% | 79,788 | -40.6% | 0.00% | – |
| Q2 2022 | $266,000 | +850.0% | 134,374 | +793.4% | 0.00% | – |
| Q1 2022 | $28,000 | +27.3% | 15,041 | -5.3% | 0.00% | – |
| Q4 2021 | $22,000 | +4.8% | 15,888 | -15.4% | 0.00% | – |
| Q3 2021 | $21,000 | -40.0% | 18,784 | -13.9% | 0.00% | – |
| Q2 2021 | $35,000 | -94.5% | 21,827 | -93.9% | 0.00% | – |
| Q1 2021 | $634,000 | -3.2% | 360,511 | +7.4% | 0.00% | – |
| Q4 2020 | $655,000 | +92.6% | 335,558 | +135.9% | 0.00% | – |
| Q3 2020 | $340,000 | +38.2% | 142,220 | +69.7% | 0.00% | – |
| Q2 2020 | $246,000 | – | 83,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |